Report Code: 11712 | Available Format: PDF | Pages: 346
Catalog Peptides Market Research Report: By Type (Cyclic, Calcitonin Gene-Related, Caspase Related, Amyloid, Adrenomedullin, Amylin, Tau, Cosmetic, Anti-Microbial, GPCR), Application (Commercial, Academic Research, Therapeutics), End-User, Geographical Outlook (U.S., Canada, Germany, France, U.K., Italy, Spain, China, Japan, India, South Korea, Singapore, Brazil, Mexico, Israel, South Africa, Saudi Arabia) – Global Industry Size, Share Analysis and Growth Forecast to 2024
- Report Code: 11712
- Available Format: PDF
- Pages: 346
- Report Description
- Table of Contents
- Market Segmentation
- Request Free Sample
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Type
1.3.2 Market Segmentation by Application
1.3.3 Market Segmentation by End User
1.3.4 Market Segmentation by Geography
1.3.5 Analysis Period
1.3.6 Market Data Reporting Unit
1.3.6.1 Value
1.4 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Type
4.1.1.1 Cyclic
4.1.1.2 Calcitonin gene-related
4.1.1.3 Caspase related
4.1.1.4 Amyloid
4.1.1.5 Adrenomedullin
4.1.1.6 Amylin
4.1.1.7 Tau
4.1.1.8 Cosmetic
4.1.1.9 Anti-microbial
4.1.1.10 GPCR
4.1.1.11 Others
4.1.2 By Application
4.1.2.1 Commercial
4.1.2.1.1 Antibody production
4.1.2.1.2 Drug discovery
4.1.2.1.3 Enzyme profiling
4.1.2.1.4 Others
4.1.2.2 Academic research
4.1.2.2.1 Disease research
4.1.2.2.1.1 Cancer and apoptosis
4.1.2.2.1.2 Cardiovascular
4.1.2.2.1.3 Diabetes
4.1.2.2.1.4 Neuroscience
4.1.2.2.1.5 Infectious diseases
4.1.2.2.1.6 Anti-inflammatory
4.1.2.2.1.7 Blood disorders
4.1.2.2.1.8 Others
4.1.2.2.2 Biomarker discovery
4.1.2.2.3 Others
4.1.2.3 Therapeutics
4.1.3 By End User
4.1.3.1 Pharmaceutical and biotechnology companies
4.1.3.2 CMOs and CROs
4.1.3.3 Academic and research institutes
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Evolution of the market with product and service launches
4.2.1.2 Increasing research activities related to recombinant proteins
4.2.2 Drivers
4.2.2.1 Development of technologies for cost-effective manufacturing
4.2.2.2 Increasing research activities to address unmet medical needs in various therapeutic areas
4.2.2.3 Growing burden of chronic diseases
4.2.2.4 Increasing investments and funding for protein-based research
4.2.2.5 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Lack of updation in regulatory standards
4.2.3.2 Contamination issues during peptide synthesis and high capital requirements for drug development
4.2.3.3 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Emerging markets in the APAC region
4.2.4.2 Rising number of approvals for peptide-based drugs
4.2.5 Challenges
4.2.5.1 Low bioavailability and short half-life of peptides
4.2.5.2 High cost of synthetic peptides
4.3 Porter’s Five Forces Analysis
4.4 Regulatory Scenario for Catalog Peptides
4.4.1 North America
4.4.2 Europe
4.5 Benefits of Catalog Peptides
Chapter 5. Global Market Size and Forecast
5.1 By Type
5.2 By Application
5.2.1 Catalog Peptides Market for Commercial Application, by Type
5.2.2 Catalog Peptides Market for Academic Research, by Type
5.2.2.1 Catalog peptides market for disease research, by type
5.3 By End User
5.4 By Region
Chapter 6. North America Market Size and Forecast
6.1 By Type
6.2 By Application
6.2.1 Catalog Peptides Market for Commercial Application, by Type
6.2.2 Catalog Peptides Market for Academic Research, by Type
6.2.2.1 Catalog peptides market for disease research, by type
6.3 By End User
6.4 By Country
6.4.1 U.S. Market Size and Forecast
6.4.1.1 By type
6.4.1.2 By application
6.4.1.2.1 Catalog peptides market for commercial application, by type
6.4.1.2.2 Catalog peptides market for academic research, by type
6.4.1.2.2.1 Catalog peptides market for disease research, by type
6.4.1.3 By end user
6.4.2 Canada Market Size and Forecast
6.4.2.1 By type
6.4.2.2 By application
6.4.2.2.1 Catalog peptides market for commercial application, by type
6.4.2.2.2 Catalog peptides market for academic research, by type
6.4.2.2.2.1 Catalog peptides market for disease research, by type
6.4.2.3 By end user
Chapter 7. Europe Market Size and Forecast
7.1 By Type
7.2 By Application
7.2.1 Catalog Peptides Market for Commercial Application, by Type
7.2.2 Catalog Peptides Market for Academic Research, by Type
7.2.2.1 Catalog peptides market for disease research, by type
7.3 By End User
7.4 By Country
7.4.1 Germany Market Size and Forecast
7.4.1.1 By type
7.4.1.2 By application
7.4.1.2.1 Catalog peptides market for commercial application, by type
7.4.1.2.2 Catalog peptides market for academic research, by type
7.4.1.2.2.1 Catalog peptides market for disease research, by type
7.4.1.3 By end user
7.4.2 France Market Size and Forecast
7.4.2.1 By type
7.4.2.2 By application
7.4.2.2.1 Catalog peptides market for commercial application, by type
7.4.2.2.2 Catalog peptides market for academic research, by type
7.4.2.2.2.1 Catalog peptides market for disease research, by type
7.4.2.3 By end user
7.4.3 U.K. Market Size and Forecast
7.4.3.1 By type
7.4.3.2 By application
7.4.3.2.1 Catalog peptides market for commercial application, by type
7.4.3.2.2 Catalog peptides market for academic research, by type
7.4.3.2.2.1 Catalog peptides market for disease research, by type
7.4.3.3 By end user
7.4.4 Italy Market Size and Forecast
7.4.4.1 By type
7.4.4.2 By application
7.4.4.2.1 Catalog peptides market for commercial application, by type
7.4.4.2.2 Catalog peptides market for academic research, by type
7.4.4.2.2.1 Catalog peptides market for disease research, by type
7.4.4.3 By end user
7.4.5 Spain Market Size and Forecast
7.4.5.1 By type
7.4.5.2 By application
7.4.5.2.1 Catalog peptides market for commercial application, by type
7.4.5.2.2 Catalog peptides market for academic research, by type
7.4.5.2.2.1 Catalog peptides market for disease research, by type
7.4.5.3 By end user
Chapter 8. APAC Market Size and Forecast
8.1 By Type
8.2 By Application
8.2.1 Catalog Peptides Market for Commercial Application, by Type
8.2.2 Catalog Peptides Market for Academic Research, by Type
8.2.2.1 Catalog peptides market for disease research, by type
8.3 By End User
8.4 By Country
8.4.1 China Market Size and Forecast
8.4.1.1 By type
8.4.1.2 By application
8.4.1.2.1 Catalog peptides market for commercial application, by type
8.4.1.2.2 Catalog peptides market for academic research, by type
8.4.1.2.2.1 Catalog peptides market for disease research, by type
8.4.1.3 By end user
8.4.2 Japan Market Size and Forecast
8.4.2.1 By type
8.4.2.2 By application
8.4.2.2.1 Catalog peptides market for commercial application, by type
8.4.2.2.2 Catalog peptides market for academic research, by type
8.4.2.2.2.1 Catalog peptides market for disease research, by type
8.4.2.3 By end user
8.4.3 India Market Size and Forecast
8.4.3.1 By type
8.4.3.2 By application
8.4.3.2.1 Catalog peptides market for commercial application, by type
8.4.3.2.2 Catalog peptides market for academic research, by type
8.4.3.2.2.1 Catalog peptides market for disease research, by type
8.4.3.3 By end user
8.4.4 South Korea Market Size and Forecast
8.4.4.1 By type
8.4.4.2 By application
8.4.4.2.1 Catalog peptides market for commercial application, by type
8.4.4.2.2 Catalog peptides market for academic research, by type
8.4.4.2.2.1 Catalog peptides market for disease research, by type
8.4.4.3 By end user
8.4.5 Singapore Market Size and Forecast
8.4.5.1 By type
8.4.5.2 By application
8.4.5.2.1 Catalog peptides market for commercial application, by type
8.4.5.2.2 Catalog peptides market for academic research, by type
8.4.5.2.2.1 Catalog peptides market for disease research, by type
8.4.5.3 By end user
Chapter 9. LATAM Market Size and Forecast
9.1 By Type
9.2 By Application
9.2.1 Catalog Peptides Market for Commercial Application, by Type
9.2.2 Catalog Peptides Market for Academic Research, by Type
9.2.2.1 Catalog peptides market for disease research, by type
9.3 By End User
9.4 By Country
9.4.1 Brazil Market Size and Forecast
9.4.1.1 By type
9.4.1.2 By application
9.4.1.2.1 Catalog peptides market for commercial application, by type
9.4.1.2.2 Catalog peptides market for academic research, by type
9.4.1.2.2.1 Catalog peptides market for disease research, by type
9.4.1.3 By end user
9.4.2 Mexico Market Size and Forecast
9.4.2.1 By type
9.4.2.2 By application
9.4.2.2.1 Catalog peptides market for commercial application, by type
9.4.2.2.2 Catalog peptides market for academic research, by type
9.4.2.2.2.1 Catalog peptides market for disease research, by type
9.4.2.3 By end user
Chapter 10. MEA Market Size and Forecast
10.1 By Type
10.2 By Application
10.2.1 Catalog Peptides Market for Commercial Application, by Type
10.2.2 Catalog Peptides Market for Academic Research, by Type
10.2.2.1 Catalog peptides market for disease research, by type
10.3 By End User
10.4 By Country
10.4.1 Israel Market Size and Forecast
10.4.1.1 By type
10.4.1.2 By application
10.4.1.2.1 Catalog peptides market for commercial application, by type
10.4.1.2.2 Catalog peptides market for academic research, by type
10.4.1.2.2.1 Catalog peptides market for disease research, by type
10.4.1.3 By end user
10.4.2 South Africa Market Size and Forecast
10.4.2.1 By type
10.4.2.2 By application
10.4.2.2.1 Catalog peptides market for commercial application, by type
10.4.2.2.2 Catalog peptides market for academic research, by type
10.4.2.2.2.1 Catalog peptides market for disease research, by type
10.4.2.3 By end user
10.4.3 Saudi Arabia Market Size and Forecast
10.4.3.1 By type
10.4.3.2 By application
10.4.3.2.1 Catalog peptides market for commercial application, by type
10.4.3.2.2 Catalog peptides market for academic research, by type
10.4.3.2.2.1 Catalog peptides market for disease research, by type
10.4.3.3 By end user
Chapter 11. Competitive Landscape
11.1 Key Players and their Product Offerings
11.2 Ranking of the Key Players
11.3 Strategic Developments of the Key Players
11.3.1 Product Launches
11.3.2 Acquisitions
11.3.3 Facility Expansions
11.3.4 Other Developments
Chapter 12. Company Profiles
12.1 PolyPeptide Group
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.2 CSBio
12.2.1 Business Overview
12.2.2 Product and Service Offerings
12.3 GL Biochem (Shanghai) Ltd.
12.3.1 Business Overview
12.3.2 Product and Service Offerings
12.4 CPC Scientific Inc.
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.5 Auspep Pty Ltd.
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.6 Peptides International Inc.
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.7 Applied Biological Materials (ABM) Inc.
12.7.1 Business Overview
12.7.2 Product and Service Offerings
12.8 Biomatik Corporation
12.8.1 Business Overview
12.8.2 Product and Service Offerings
12.9 Bio-Synthesis Inc.
12.9.1 Business Overview
12.9.2 Product and Service Offerings
12.10 Thermo Fisher Scientific Inc.
12.10.1 Business Overview
12.10.2 Product and Service Offerings
12.10.3 Key Financial Summary
12.11 GenScript Biotech Corporation
12.11.1 Business Overview
12.11.2 Product and Service Offerings
12.11.3 Key Financial Summary
12.12 Bachem AG
12.12.1 Business Overview
12.12.2 Product and Service Offerings
12.12.3 Key Financial Summary
12.13 JPT Peptide Technologies GmbH
12.13.1 Business Overview
12.13.2 Product and Service Offerings
12.14 Advanced ChemTech
12.14.1 Business Overview
12.14.2 Product and Service Offerings
12.15 LifeTein LLC
12.15.1 Business Overview
12.15.2 Product and Service Offerings
12.16 Kaneka Eurogentec S.A.
12.16.1 Business Overview
12.16.2 Product and Service Offerings
12.17 Elim Biopharm Inc.
12.17.1 Business Overview
12.17.2 Product and Service Offerings
12.18 Creative Peptides
12.18.1 Business Overview
12.18.2 Product and Service Offerings
12.19 Abbiotec Inc.
12.19.1 Business Overview
12.19.2 Product and Service Offerings
12.20 NovoPro Bioscience Inc.
12.20.1 Business Overview
12.20.2 Product and Service Offerings
12.21 KareBay Biochem Inc.
12.21.1 Business Overview
12.21.2 Product and Service Offerings
12.22 Ontores Biotechnologies Inc.
12.22.1 Business Overview
12.22.2 Product and Service Offerings
12.23 Severn Biotech Ltd.
12.23.1 Business Overview
12.23.2 Product and Service Offerings
12.24 Genway Biotech Inc.
12.24.1 Business Overview
12.24.2 Product and Service Offerings
12.25 Kaneka Corporation
12.25.1 Business Overview
12.25.2 Product and Service Offerings
12.25.3 Key Financial Summary
12.26 New England Peptide Inc.
12.26.1 Business Overview
12.26.2 Product and Service Offerings
12.27 AnaSpec Inc.
12.27.1 Business Overview
12.27.2 Product and Service Offerings
12.28 AAPPTec LLC
12.28.1 Business Overview
12.28.2 Product and Service Offerings
12.29 Merck KGaA
12.29.1 Business Overview
12.29.2 Product and Service Offerings
12.29.3 Key Financial Summary
Chapter 13. Appendix
13.1 Abbreviations
13.2 Sources and References
13.3 Related Reports
LIST OF TABLES
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 NUMBER OF DEATHS DUE TO VARIOUS DISEASES WORLDWIDE
TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 5 GLOBAL CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 6 GLOBAL CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 7 GLOBAL CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 8 GLOBAL CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 9 GLOBAL CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 10 GLOBAL CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 11 GLOBAL CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 12 GLOBAL CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 13 GLOBAL CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 14 GLOBAL CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 15 GLOBAL CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 16 GLOBAL CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 17 GLOBAL CATALOG PEPTIDES MARKET, BY REGION, $’000 (2019–2024)
TABLE 18 GLOBAL CATALOG PEPTIDES MARKET, BY REGION, $’000 (2019-2024)
TABLE 19 NORTH AMERICA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 20 NORTH AMERICA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 21 NORTH AMERICA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 22 NORTH AMERICA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 23 NORTH AMERICA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 24 NORTH AMERICA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 25 NORTH AMERICA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 26 NORTH AMERICA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 27 NORTH AMERICA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 28 NORTH AMERICA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 29 NORTH AMERICA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 30 NORTH AMERICA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 31 NORTH AMERICA CATALOG PEPTIDES MARKET, BY COUNTRY, $’000 (2019–2024)
TABLE 32 NORTH AMERICA CATALOG PEPTIDES MARKET, BY COUNTRY, $’000 (2019-2024)
TABLE 33 U.S. CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 34 U.S. CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 35 U.S. CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 36 U.S. CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 37 U.S. CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 38 U.S. CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 39 U.S. CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 40 U.S. CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 41 U.S. CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 42 U.S. CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 43 U.S. CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 44 U.S. CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 45 CANADA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 46 CANADA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 47 CANADA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 48 CANADA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 49 CANADA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 50 CANADA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 51 CANADA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 52 CANADA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 53 CANADA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 54 CANADA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 55 CANADA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 56 CANADA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 57 EUROPE CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 58 EUROPE CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 59 EUROPE CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 60 EUROPE CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 61 EUROPE CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 62 EUROPE CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 63 EUROPE CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 64 EUROPE CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 65 EUROPE CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 66 EUROPE CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 67 EUROPE CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 68 EUROPE CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 69 EUROPE CATALOG PEPTIDES MARKET, BY COUNTRY, $’000 (2019–2024)
TABLE 70 EUROPE CATALOG PEPTIDES MARKET, BY COUNTRY, $’000 (2019-2024)
TABLE 71 GERMANY CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 72 GERMANY CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 73 GERMANY CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 74 GERMANY CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 75 GERMANY CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 76 GERMANY CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 77 GERMANY CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 78 GERMANY CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 79 GERMANY CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 80 GERMANY CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 81 GERMANY CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 82 GERMANY CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 83 FRANCE CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 84 FRANCE CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 85 FRANCE CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 86 FRANCE CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 87 FRANCE CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 88 FRANCE CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 89 FRANCE CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 90 FRANCE CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 91 FRANCE CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 92 FRANCE CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 93 FRANCE CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 94 FRANCE CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 95 U.K. CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 96 U.K. CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 97 U.K. CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 98 U.K. CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 99 U.K. CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 100 U.K. CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 101 U.K. CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 102 U.K. CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 103 U.K. CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 104 U.K. CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 105 U.K. CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 106 U.K. CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 107 ITALY CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 108 ITALY CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 109 ITALY CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 110 ITALY CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 111 ITALY CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 112 ITALY CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 113 ITALY CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 114 ITALY CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 115 ITALY CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 116 ITALY CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 117 ITALY CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 118 ITALY CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 119 SPAIN CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 120 SPAIN CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 121 SPAIN CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 122 SPAIN CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 123 SPAIN CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 124 SPAIN CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 125 SPAIN CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 126 SPAIN CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 127 SPAIN CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 128 SPAIN CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 129 SPAIN CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 130 SPAIN CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 131 APAC CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 132 APAC CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 133 APAC CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 134 APAC CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 135 APAC CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 136 APAC CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 137 APAC CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 138 APAC CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 139 APAC CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 140 APAC CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 141 APAC CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 142 APAC CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 143 APAC CATALOG PEPTIDES MARKET, BY COUNTRY, $’000 (2019–2024)
TABLE 144 APAC CATALOG PEPTIDES MARKET, BY COUNTRY, $’000 (2019-2024)
TABLE 145 CHINA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 146 CHINA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 147 CHINA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 148 CHINA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 149 CHINA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 150 CHINA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 151 CHINA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 152 CHINA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 153 CHINA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 154 CHINA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 155 CHINA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 156 CHINA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 157 JAPAN CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 158 JAPAN CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 159 JAPAN CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 160 JAPAN CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 161 JAPAN CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 162 JAPAN CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 163 JAPAN CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 164 JAPAN CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 165 JAPAN CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 166 JAPAN CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 167 JAPAN CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 168 JAPAN CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 169 INDIA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 170 INDIA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 171 INDIA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 172 INDIA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 173 INDIA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 174 INDIA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 175 INDIA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 176 INDIA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 177 INDIA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 178 INDIA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 179 INDIA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 180 INDIA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 181 SOUTH KOREA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 182 SOUTH KOREA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 183 SOUTH KOREA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 184 SOUTH KOREA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 185 SOUTH KOREA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 186 SOUTH KOREA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 187 SOUTH KOREA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 188 SOUTH KOREA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $000 (2025–2030)
TABLE 189 SOUTH KOREA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 190 SOUTH KOREA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 191 SOUTH KOREA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 192 SOUTH KOREA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 193 SINGAPORE CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 194 SINGAPORE CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 195 SINGAPORE CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 196 SINGAPORE CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 197 SINGAPORE CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 198 SINGAPORE CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 199 SINGAPORE CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 200 SINGAPORE CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 201 SINGAPORE CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 202 SINGAPORE CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 203 SINGAPORE CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 204 SINGAPORE CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 205 LATAM CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 206 LATAM CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 207 LATAM CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 208 LATAM CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 209 LATAM CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 210 LATAM CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 211 LATAM CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 212 LATAM CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 213 LATAM CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 214 LATAM CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 215 LATAM CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 216 LATAM CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 217 LATAM CATALOG PEPTIDES MARKET, BY COUNTRY, $’000 (2019–2024)
TABLE 218 LATAM CATALOG PEPTIDES MARKET, BY COUNTRY, $’000 (2019-2024)
TABLE 219 BRAZIL CATALOG PEPTIDES MARKET, BY TYPE, $$’000 (2019–2024)
TABLE 220 BRAZIL CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 221 BRAZIL CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 222 BRAZIL CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 223 BRAZIL CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 224 BRAZIL CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 225 BRAZIL CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 226 BRAZIL CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 227 BRAZIL CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 228 BRAZIL CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 229 BRAZIL CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 230 BRAZIL CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 231 MEXICO CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 232 MEXICO CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 233 MEXICO CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 234 MEXICO CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 235 MEXICO CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 236 MEXICO CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 237 MEXICO CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 238 MEXICO CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 239 MEXICO CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 240 MEXICO CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 241 MEXICO CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 242 MEXICO CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 243 MEA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 244 MEA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 245 MEA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 246 MEA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 247 MEA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 248 MEA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 249 MEA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 250 MEA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 251 MEA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 252 MEA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 253 MEA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 254 MEA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 255 MEA CATALOG PEPTIDES MARKET, BY COUNTRY, $’000 (2019–2024)
TABLE 256 MEA CATALOG PEPTIDES MARKET, BY COUNTRY, $’000 (2019-2024)
TABLE 257 ISRAEL CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 258 ISRAEL CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 259 ISRAEL CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 260 ISRAEL CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 261 ISRAEL CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 262 ISRAEL CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 263 ISRAEL CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 264 ISRAEL CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 265 ISRAEL CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 266 ISRAEL CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 267 ISRAEL CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 268 ISRAEL CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 269 SOUTH AFRICA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 270 SOUTH AFRICA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 271 SOUTH AFRICA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 272 SOUTH AFRICA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 273 SOUTH AFRICA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 274 SOUTH AFRICA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 275 SOUTH AFRICA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 276 SOUTH AFRICA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 277 SOUTH AFRICA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 278 SOUTH AFRICA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 279 SOUTH AFRICA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 280 SOUTH AFRICA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 281 SAUDI ARABIA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2024)
TABLE 282 SAUDI ARABIA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2025–2030)
TABLE 283 SAUDI ARABIA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2024)
TABLE 284 SAUDI ARABIA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2025–2030)
TABLE 285 SAUDI ARABIA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2019–2024)
TABLE 286 SAUDI ARABIA CATALOG PEPTIDES MARKET FOR COMMERCIAL APPLICATION, BY TYPE, $’000 (2025–2030)
TABLE 287 SAUDI ARABIA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 288 SAUDI ARABIA CATALOG PEPTIDES MARKET FOR ACADEMIC RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 289 SAUDI ARABIA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2019–2024)
TABLE 290 SAUDI ARABIA CATALOG PEPTIDES MARKET FOR DISEASE RESEARCH, BY TYPE, $’000 (2025–2030)
TABLE 291 SAUDI ARABIA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2024)
TABLE 292 SAUDI ARABIA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2025–2030)
TABLE 293 POLYPEPTIDE GROUP – AT A GLANCE
TABLE 294 CSBIO – AT A GLANCE
TABLE 295 GL BIOCHEM (SHANGHAI) LTD. – AT A GLANCE
TABLE 296 CPC SCIENTIFIC INC. – AT A GLANCE
TABLE 297 AUSPEP PTY LTD. – AT A GLANCE
TABLE 298 PEPTIDES INTERNATIONAL INC. – AT A GLANCE
TABLE 299 APPLIED BIOLOGICAL MATERIALS (ABM) INC. – AT A GLANCE
TABLE 300 BIOMATIK CORPORATION – AT A GLANCE
TABLE 301 BIO-SYNTHESIS INC. – AT A GLANCE
TABLE 302 THERMO FISHER SCIENTIFIC INC. – AT A GLANCE
TABLE 303 THERMO FISHER SCIENTIFIC INC. – KEY FINANCIAL SUMMARY
TABLE 304 GENSCRIPT BIOTECH CORPORATION – AT A GLANCE
TABLE 305 GENSCRIPT BIOTECH CORPORATION – KEY FINANCIAL SUMMARY
TABLE 306 BACHEM AG – AT A GLANCE
TABLE 307 BACHEM AG – KEY FINANCIAL SUMMARY
TABLE 308 JPT PEPTIDE TECHNOLOGIES GMBH – AT A GLANCE
TABLE 309 ADVANCED CHEMTECH – AT A GLANCE
TABLE 310 LIFETEIN LLC – AT A GLANCE
TABLE 311 KANEKA EUROGENTEC S.A. – AT A GLANCE
TABLE 312 ELIM BIOPHARM INC. – AT A GLANCE
TABLE 313 CREATIVE PEPTIDES – AT A GLANCE
TABLE 314 ABBIOTEC INC. – AT A GLANCE
TABLE 315 NOVOPRO BIOSCIENCE INC. – AT A GLANCE
TABLE 316 KAREBAY BIOCHEM INC. – AT A GLANCE
TABLE 317 ONTORES BIOTECHNOLOGIES INC. – AT A GLANCE
TABLE 318 SEVERN BIOTECH LTD. – AT A GLANCE
TABLE 319 GENWAY BIOTECH INC. – AT A GLANCE
TABLE 320 KANEKA CORPORATION – AT A GLANCE
TABLE 321 KANEKA CORPORATION – KEY FINANCIAL SUMMARY
TABLE 322 NEW ENGLAND PEPTIDE INC. – AT A GLANCE
TABLE 323 ANASPEC INC. – AT A GLANCE
TABLE 324 AAPPTECH LLC – AT A GLANCE
TABLE 325 MERCK KGAA – AT A GLANCE
TABLE 326 MERCK KGAA – KEY FINANCIAL SUMMARY
LIST OF FIGURES
FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
FIG 7 DATA TRIANGULATION APPROACH
FIG 8 GLOBAL CATALOG PEPTIDES MARKET SUMMARY
FIG 9 BARGAINING POWER OF BUYERS
FIG 10 BARGAINING POWER OF SUPPLIERS
FIG 11 INTENSITY OF RIVALRY
FIG 12 THREAT OF NEW ENTRANTS
FIG 13 THREAT OF SUBSTITUTES
FIG 14 SNAPSHOT OF GLOBAL CATALOG PEPTIDES MARKET
FIG 15 GLOBAL CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2030)
FIG 16 GLOBAL CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2030)
FIG 17 GLOBAL CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2030)
FIG 18 WORLDWIDE MAJOR MARKETS FOR CATALOG PEPTIDES
FIG 19 NORTH AMERICA CATALOG PEPTIDES MARKET SNAPSHOT
FIG 20 NORTH AMERICA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2030)
FIG 21 NORTH AMERICA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2030)
FIG 22 NORTH AMERICA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2030)
FIG 23 NORTH AMERICA CATALOG PAPTIDES MARKET, BY COUNTRY, $’000 (2019–2030)
FIG 24 EUROPE CATALOG PEPTIDES MARKET SNAPSHOT
FIG 25 EUROPE CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2030)
FIG 26 EUROPE CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2030)
FIG 27 EUROPE CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2030)
FIG 28 EUROPE CATALOG PEPTIDES MARKET, BY COUNTRY, $’000 (2019–2030)
FIG 29 APAC CATALOG PEPTIDES MARKET SNAPSHOT
FIG 30 APAC CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2030)
FIG 31 APAC CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2030)
FIG 32 APAC CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2030)
FIG 33 APAC CATALOG PAPETIDES MARKET, BY COUNTRY, $’000 (2019–2030)
FIG 34 LATAM CATALOG PEPTIDES MARKET SNAPSHOT
FIG 35 LATAM CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2030)
FIG 36 LATAM CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2030)
FIG 37 LATAM CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2030)
FIG 38 LATAM CATALOG PEPTIDES MARKET, BY COUNTRY, $’000 (2019–2030)
FIG 39 MEA CATALOG PEPTIDES MARKET SNAPSHOT
FIG 40 MEA CATALOG PEPTIDES MARKET, BY TYPE, $’000 (2019–2030)
FIG 41 MEA CATALOG PEPTIDES MARKET, BY APPLICATION, $’000 (2019–2030)
FIG 42 MEA CATALOG PEPTIDES MARKET, BY END USER, $’000 (2019–2030)
FIG 43 MEA CATALOG PEPTIDES MARKET, BY COUNTRY, $’000 (2019–2030)
FIG 44 KEY PLAYERS OFFERINGS
FIG 45 RANKING OF THE KEY PLAYERS
FIG 46 THERMO FISHER SCIENTIFIC INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
FIG 47 GENESCRIPT BIOTECH CORPORATION – REVENUE SPLIT BY PRODUCT AND GEOGRAPHY (2023)
FIG 48 BACHEM AG – REVENUE SPLIT BY PRODUCT AND GEOGRAPHY (2023)
FIG 49 MERCK KGAA – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to Analyst
Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws